Program 2026
DAY 1 - DTx NEW NORDICS 2026 - NORDIC-BALTIC HEALTH INFORMATICS DAY
AGENDA
| TIME | AGENDA ITEM | SPEAKERS & TOPICS |
|---|---|---|
| 09:30–09:45 | Registration & Welcome Coffee | |
| 09:45–10:00 | Opening Remarks | Karmen JOLLER - Minister of Social Affairs - Estonia (TBC) |
| 10:00–10:30 | Setting the Scene (Welcome address by host/moderator) | Dipak Kalra – Professor of Health Informatics, UCL / President, The European Institute for Innovation through Health Data (i~HD) – EHDS opportunities and responsibilities, interoperability and trust in health data – UK |
| 10:30–12:00 | Session I Clinical Leadership and Technology Strategy | Moderator: Lars Lindsköld
|
| 12:00–13:00 | Lunch Break | |
| 13:00–14:30 | Session II Health Data Governance and EHDS Implementation | Moderator: Elina Drakvik
|
| 14:30–15:00 | Coffee Break & Networking | |
| 15:00–16:30 | Session III From Data to Impact: Patient-Centred Innovations and National Platforms | Moderator: Dipak Kalra
|
| 16:30–17:00 | Coffee Break & Networking | |
| 17:00–18:00 | Panel Discussion The programme will conclude with a panel of government representatives, offering national perspectives on the direction of developments in health data use, digital health systems and the implementation of the European Health Data Space. | Government representatives – (TBC) |
| 18:00–18:05 | Closing Remarks |
DAY 2 - DTx NEW NORDICS - PERSONALISED MEDICINE, PREVENTION & AI
AGENDA
TIME | AGENDA ITEM | SPEAKERS & TOPICS |
| 09:30–10:00 | Registration & Morning Coffee | |
| 10:00–10:30 | Keynote (Setting the Scene) | TBC |
| 10:00–10:30 | Session I: Personalised medicine - do we have enough data? This session discusses the practical aspects of personal medicine and prevention. | Moderator: Andres Metspalu, Professor of Genomics and Biobanking /Professor of Biotechnology at the University of Tartu – Estonia
|
| 12:00–13:00 | Lunch & Networking | |
| 13:00–14:30 | Session II Beyond the Hype: Personalised Medicine with MedTech & AI - Legal and Practical Challenges This session discusses the practical and legal issues related to the use of cutting-edge medtech solutions and AI applications that enable patient-specific interventions. But turning these breakthroughs into real-world patient benefit requires more than just technical excellence - it demands navigating a complex landscape of legal, regulatory, and practical hurdles. We will dive into the realities of implementing AI-driven medtech in personalised care by discussing practical challenges related to the legal frameworks (including EU MDR/IVDR, EU AI Act, GDPR) and the operational challenges of integrating new technologies into healthcare systems. | Moderator: Lise-Lotte Lääne, Partner, Head of Life Sciences & Healthcare at Sorainen – Estonia
|
| 14:30–15:00 | Coffee Break | |
| 15:00–16:30 | Session III Health economics This session discusses how personalised medicine, prevention, and AI can be embedded into healthcare in a way that delivers measurable value and remains financially sustainable. It will examine the practical feasibility of reusing health data to enable earlier risk detection and more tailored interventions, alongside the governance and incentive structures such approaches require. The session will also consider how to evaluate and fund these models, balancing long-term benefits with short-term budget and implementation | Moderator: TBC
|
| 16:30–16:45 | Coffee Break | |
| 16:30–16:45 | Session IV Preventive medicine This session explores the implementation of preventive medicine service models in Estonia, with a focus on breast cancer prevention, as well as models for prostate cancer and cardiovascular diseases. The discussion will address challenges around the transition towards risk-based prevention. The session also highlights Estonia’s testbed potential, demonstrating how a small market can enable faster adoption of innovative preventive healthcare models. | Moderator: Krista Kruuv-Käo, Head of preventive services at Estonian Health Insurance Fund – Estonia
|